Spinal Imaging in Neuropathy of Diabetes: Longitudinal Evaluation (SpINDLE)

niversity of Nottingham0 个研究点目标入组 115 人开始时间: 2021年4月8日最近更新: 2023年1月9日

适应症

试验速览

暂无简介。

•1. Aged between 18 and 75 years
•2. Able to give informed consent
•3. Able to speak and understand English language
•4. Diagnosis consistent with one of the study groups (diabetes without diabetic peripheral neuropathy, diabetes with diabetic peripheral neuropathy, healthy volunteers, multiple sclerosis, or other peripheral neuropathies) with initial symptoms having preceded inclusion into the study by 12 months and/or condition stable for =2 months

•1. Extensive cardiovascular and/or cerebrovascular comorbidity (treatment for angina or peripheral vascular disease constitutes a contraindication)
•2. Other comorbidities, in particular neurological diseases, that in view of the researcher may interfere with the study
•3. Significant spinal or spinal cord disease (other than MS in the MS control group)
•4. Contraindications for MRI including but not restricted to pacemaker, orbital foreign body, certain aneurysm clips, claustrophobia, and un-removable piercings
•5. Pregnancy or planning for pregnancy

发起方

niversity of Nottingham